We’re back! Earnings are fantastically interesting right now, with AI spending surging and results coming in stronger than the pessimists might have expected.

We’ve been writing endlessly about the importance of networking and optical to the AI buildout — you’ve seen it lately in the stock results of Applied Optoelectronics (AAOI:NASADQ), Coherent (COHR:NASADQ) and Fabrinet (FN:NYSE) of late (up 909%, 375% and 199% in the last year, respectively.) Corning (GLW:NYSE), which we also warned you about (remember this) was a big benificiary last week after NVIDIA (NVDA:NASDAQ) made a multi-billion-dollar prepayment to fund new U.S. glass factories, on top of potential $3.2 billion equity stake.

With that in mind Cisco (CSCO:NASDAQ) earnings this coming week could be particularly interesting. (We’re also hearing rumblings of some important database news at ORCL:NASDAQ — hence our meeting with management next week.)

Finally, we think the SpaceX IPO S-1 filing could be made public by Friday. 🚀

You can find prior notes and the full research archive at https://epistrophy.beehiiv.com.

As always, I’m focused on three things:
1) Technology-driven change;
2) the latest in innovation and startup trends, and;
3) stock fraud.

Companies Discussed

In This Note:

1. Companies Discussed

2. CoreWeave’s Gamble

   1. A race of obsolescence vs. leverage 

3. Tweet O’ The Week

4. Epistrophy In The News

5. 📆 of Epistrophy Events

6. Availability This Week

CoreWeave’s Gamble

A race of obsolescence vs. leverage 

CoreWeave’s quarter looked, at first glance, like another triumph of AI infrastructure excess: revenue doubled, backlog approached $100 billion and management spoke in excited gigawatts tongues. But Thursday’s earnings call also sharpened the central tension in the CoreWeave story. The company is borrowing enormous sums against rapidly depreciating hardware in order to satisfy a demand curve that may already be flattening at the margins.

The market heard that tension immediately. Shares fell nearly 10% after CoreWeave’s Q2 guidance missed expectations and management declined to raise full-year forecasts despite record backlog growth.

CoreWeave (CRWV:NASDAQ) increasingly resembles less a conventional cloud company than a highly leveraged financing vehicle wrapped around NVIDIA GPUs. The company finances massive purchases of AI infrastructure with long-duration debt, then attempts to monetize those assets before they become technologically obsolete. That structure has produced extraordinary top-line growth. It has also produced a balance sheet carrying nearly $25 billion of debt, almost $10 billion of lease liabilities and less than $5 billion of equity.

The latest quarter magnified the imbalance.

Revenue reached $2.08 billion, up 112% year over year. But operating expenses rose even faster to $2.22 billion, producing a quarterly operating loss of $144 million. Interest expense alone exploded to $536 million from $264 million a year earlier. Net loss widened to $740 million.

CoreWeave is increasingly dependent on financial engineering to sustain the expansion. Management highlighted an $8.5 billion delayed-draw facility backed by GPUs and customer contracts, including Meta agreements. The company now appears intent on turning both chips and customer commitments into collateral in order to lower borrowing costs.

That strategy works only if three assumptions hold simultaneously:

1. AI demand remains structurally undersupplied.

2. NVIDIA hardware retains value longer than historical compute cycles suggest.

3. Customers continue signing multi-year commitments faster than CoreWeave accumulates debt.

Thursday’s conference call introduced more uncertainty into all three.

Management guided Q2 revenue to $2.45 billion to $2.6 billion, cutting it’s sequential growth rate by nearly a third (from 32% to 22%). Adjusted operating income guidance of $30 million to $90 million was, well, income (money losing company also has lost money excluding its interest expenses in three of the last five quarters), but woeful nonetheless.

The explanation from management was essentially temporal: CoreWeave claims it is incurring the costs of bringing new capacity online before associated revenue begins flowing. Investors, however, are being asked to trust that future utilization will outrun present financing costs.

That is becoming a larger leap of faith.

CoreWeave spent $7.7 billion on property and equipment in a single quarter. Full-year capital expenditures are now expected to reach $31 billion to $35 billion. This is no longer venture-style hypergrowth. It is industrial-scale infrastructure financing.

And unlike railroads, pipelines or hyperscale real estate, the underlying assets here are GPUs with uncertain residual value.

CoreWeave depreciates its GPU-heavy infrastructure over six years. Are we really to believe that this year’s Nvidia Blackwell will still be useful for AI workloads in six years? Can you wear the same dress to the Met Ball year after year? Or can we expect rapid innovation and, therefore, rapid obsolesces?

NVIDIA’s innovation cadence now approaches annual architectural replacement cycles: Hopper, Blackwell, Rubin. Management insists older GPUs remain in demand, pointing to rising prices for A100s and H100s during the quarter. But there is little historical evidence that frontier AI accelerators maintain premium economics for six years under continuous high-intensity utilization.

The danger is not merely accounting. It is refinancing.

If GPU resale values deteriorate faster than expected, collateral coverage weakens precisely as billions in debt mature. CoreWeave then faces a classic leveraged infrastructure problem: refinancing short-lived assets with longer-duration liabilities in a potentially less euphoric capital market.

Even the celebrated backlog deserves scrutiny.

CoreWeave ended Q1 with $98.8 billion of remaining performance obligations. But RPO is not equivalent to cash flow. The company itself acknowledges the figure incorporates assumptions around delivery timing, variable consideration and cloud capacity that may ultimately be resold.

Moreover, only 36% of that backlog is expected to convert into revenue over the next two years. Nearly two-thirds stretches beyond 2028. Investors are effectively capitalizing contracts dependent on assumptions about AI demand, power availability, chip relevance and customer solvency years into the future.

Meanwhile, concentration risk remains extreme.

One customer still represented 45% of Q1 revenue. Two customers accounted for 56% combined. The names shift quarter to quarter, but the underlying dependence on a handful of hyperscalers and frontier labs remains.

Management emphasized diversification into financial services and physical AI. Jane Street alone reportedly added $6 billion of backlog during the quarter. Yet much of this diversification still depends on industries experimenting with AI economics that remain largely unproven at scale.

There is another subtle warning embedded in the quarter: backlog is growing faster than revenue conversion.

CoreWeave added more than $40 billion of new commitments in Q1 alone. Yet despite nearly $100 billion of backlog, full-year revenue guidance remained unchanged at $12 billion to $13 billion. The bottleneck increasingly appears not demand, but deployment.

That shifts the business from a software-style scaling story into something closer to heavy construction and utility management: power procurement, cooling infrastructure, networking integration and data center execution. Those businesses historically produce lower margins and higher operational risk than investors generally associate with AI.

CoreWeave insists this is merely the painful middle phase before operating leverage emerges. Perhaps. But yesterday’s market reaction suggested investors are beginning to ask whether the company’s growth narrative is outrunning the economics underneath it.

The neocloud model depends on a simple proposition: AI demand compounds faster than depreciation, financing costs and competition.

Yesterday’s quarter showed demand still compounding.

It also showed the other variables accelerating.

Tweet O’ The Week

Epistrophy In The News

It was a treat being on with Nichole Burlie of NewsNation to discuss Gamestop’s (GME:NYSE) ludicrous “bid” for Ebay (EBAY:NASDAQ). NewsNation also had me on to talk about the importance of Elon Musk’s suit against OpenAI’s leadership. And we had a fun hit on SchwabTV to preview CoreWeave’s earnings. We predicted weakness and got it.

📆 of Epistrophy Events

Availability This Week

I’ll be in our San Francisco office at the Ferry Building early in the week, in Nashville with a client on Thursday and in New York City meeting with clients about the SpaceX IPO on Friday — and doing lots of media throughout. Reach out!

Written reports are available to clients, with video summaries on YouTube, and of course our popular summaries of the summaries on Instagram, TikTok, and YouTube Shorts.